Author
Correspondence author
Biological Evidence, 2025, Vol. 15, No. 5
Received: 03 Aug., 2025 Accepted: 11 Sep., 2025 Published: 24 Sep., 2025
The gluten in wheat is the key to making staple foods like bread taste good. But it is also the main cause of celiac disease and some gluten intolerance diseases. Nowadays, there are many ways to reduce gluten, such as RNA interference, gene editing, mutagenesis screening and molecular marker breeding. Gene editing technologies like CRISPR/Cas9 can precisely knock out or modify multiple copies of the alcohol-soluble protein gene. This can significantly reduce the immune response while still retaining the processing performance of the dough. Researchers have obtained low-gluten wheat strains without genetically modified residues. Methods such as RNAi and TILLING can also lower the level of low-gluten protein and improve the nutritional components of wheat. These improvement measures not only offer celiac disease patients safer choices of staple foods, but also drive the development of healthy foods. In the future, if multi-omics analysis, personalized breeding and synthetic biology can be combined, it is possible to cultivate a new generation of low-gluten wheat that is both safe and delicious. This is precisely the goal of our research.
1 Introduction
Wheat is one of the world's most important food crops, providing energy and protein for billions of people. It can be cultivated in many regions not only because of its high yield and strong adaptability, but also because gluten protein gives bread, noodles and other foods good taste and processing performance (Sanzan-Leon et al., 2017; Pourmohammadi et al., 2023). Gluten is mainly composed of two types of proteins: gliadins and glutenins. Glutenin makes the dough sticky, while glutenin gives it elasticity. The two work together to form the special properties of wheat dough, which is an important basis for making bread and baked goods (Jouanin et al., 2020).
However, some small fragments in gluten, especially the immunogenic epitopes in α-, γ- and ω -olysin, can cause diseases in some populations, such as celiac disease, non-celiac gluten sensitivity (NCGS), and wheat allergy (Sanchez-Leon et al., 2017; Jouanin et al., 2020; Sharma et al., 2020; Asri et al., 2021) Patients with celiac disease must adhere to a gluten-free diet for life. However, gluten-free foods often require additives, have poor taste and unbalanced nutrition, which makes it difficult for patients to adhere to.
Traditional methods, such as fermentation, enzymatic hydrolysis or physical separation, although they can partially reduce gluten, often damage dough performance and are difficult to completely remove harmful fragments (Jouanin et al., 2017; Pilolli et al., 2019; Sharma et al., 2020). In recent years, genetic improvement has become a research focus. Scientists used methods such as RNA interference (RNAi), gene editing (CRISPR/Cas9), and mutagenesis to silence, knockout or modify the genes of alcohol-soluble proteins and some gluten proteins. The results showed that these methods could significantly reduce gluten content and immune activity while maintaining dough quality to the greatest extent (Sanchet-Leon et al., 2017; Jouanin et al., 2019; Moehs et al., 2019; Jouanin et al., 2020; Asri et al., 2021; Wen et al., 2022; Bennur et al., 2024).
This study will sort out the genetic methods used in the research of low gluten in wheat in recent years, with a focus on the principles and effects of gene editing, RNAi and mutagenesis. It will also discuss their impact on quality and safety, as well as issues related to screening, detection and regulations. Finally, the advantages and disadvantages of different strategies will be compared to explore how to cultivate low-gluten wheat that is both safe and of high quality, providing better staple food options for patients with celiac disease and related conditions.
2 Gluten Proteins: Structure and Function
2.1 Overview of wheat seed storage proteins (prolamins)
The main storage protein in wheat grains is prolamins, collectively known as gluten, which accounts for approximately 80% of the total protein in wheat. Gluten proteins are divided into two types: monomer gliadins and polymerized glutenins. These two types of proteins jointly determine the special processing properties of wheat dough (Biesiekierski, 2017; Wang et al., 2020; Wieser et al., 2022).
2.2 Molecular organization of gliadins and glutenins
Alcohol-soluble proteins can be classified into α-, β-, γ- and ω- types based on molecular weight and electrophoretic characteristics, with molecular weights ranging from 30 000 to 80 000 Da. They contain a lot of glutamine and proline, mainly composed of repetitive sequences, lacking cysteine, and generally exist as monomers (Wang et al., 2020; Wieser et al., 2022). Gluten is classified into two types: high molecular weight (HMW-GS, 80 000-160 000 Da) and low molecular weight (LMW-GS, 30 000-51 000 Da). They are rich in cysteine and can form macromolecular polymers through disulfide bonds, forming the gluten network. Both types of proteins have central repetitive domains and non-repetitive N/ C-terminal domains. The gluten subunits also maintain the three-dimensional structural skeleton through disulfide bonds and hydrogen bonds, etc. (Shewry et al., 2002).
2.3 Their role in dough elasticity and baking performance
The special structure of gluten protein endows wheat dough with excellent processing characteristics. Glutenin mainly provides viscosity and extensibility, while gluten determines the elasticity and strength of the dough. High-molecular-weight gluten forms a three-dimensional network through disulfide bonds, which is the key to elasticity. Low-molecular-weight gluten and gliadin regulate plasticity and adaptability (Shewry et al., 2002; Biesiekierski, 2017; Wang et al., 2020). The proportion and polymerization state of gluten protein will directly affect the volume, structure and taste of bread and noodles.
2.4 Immunogenic peptides responsible for triggering celiac disease (e.g., 33-mer in α-gliadin)
Some gluten proteins, especially α -alcohol-soluble proteins, contain peptides with strong immunogenicity. One of the most typical is 33 - peptide (33 - killing, LQLQPFPQPQLPYPQPQLPYPQPQLPYPQPQPF). It is not easily broken down by digestive enzymes and can induce celiac disease in genetically susceptible populations (Biesiekierski, 2017; Schalk et al., 2017; Shewry, 2019; Wang et al., 2020). These peptides are rich in glutamine and proline and are easily modified by tissue transglutaminase, thereby better binding to HLA-DQ2/8 molecules, activating T cells and triggering immune responses, which is the molecular basis for the occurrence of celiac disease.
3 Conventional Breeding Approaches
3.1 Historical breeding attempts to reduce immunogenic proteins
Traditional breeding methods, such as variety selection, hybridization, backcrossing and mutagenesis, have always been mainly used to increase the yield and processing quality of wheat. However, there is not much breeding work specifically aimed at reducing immunogenic proteins such as gliadin and glutenin. Research has found that there are significant differences among different wheat varieties and related species in terms of gluten protein content and the number of immunogenic epitopes. Hard-grain wheat and some wild species usually have lower immunogenicity (Ozuna and Barro, 2018; Pilolli et al., 2019; Marin-Sanz et al., 2023). In addition, mutagenesis breeding methods (such as gamma-ray and EMS mutagenesis) have also been used to obtain mutants lacking certain gluten genes. These mutants sometimes exhibit a decrease in immunogenic proteins (Jouanin et al., 2019; 2020).
3.2 Trade-offs between low-gluten content and technological properties
Reducing gluten protein often causes problems. Because gluten is the key to forming the dough structure, reducing it will affect elasticity, extensibility and baking performance (Jouanin et al., 2019; Pilolli et al., 2019; Call et al., 2020; Jouanin et al., 2020). For instance, those mutants lacking alcohol-soluble protein or low-molecular-weight gluten, although having lower immunogenicity, often have poorer dough quality, and the volume and texture of the bread made are also not good. Therefore, conventional breeding needs to strike a balance between reducing immunogenicity and maintaining the integrity of the gluten network, and also meet the needs of the food industry.
3.3 Use of natural genetic variation within wheat and related species
Wheat and its related species have rich natural differences in gluten composition and the number of immunogenic epitopes. Studies have shown that the immunogenicity of α- and γ -olysis proteins in durum wheat, some wild species and hybrids (such as the wheat-rye hybrid tritordeum) is lower than that in common wheat (Ozuna and Barro, 2018; Pilolli et al., 2019; Marin-Sanz et al., 2023). These genotypes can be used as parents for breeding, and common varieties can be introduced through hybridization or backcrossing, thereby gradually reducing the immunogenicity of gluten. In addition, directed deletion of chromosomal fragments or the use of chromosomal translocations (such as 1BL/1RS rye translocations) can also regulate gluten composition, providing more means for breeding (Pilolli et al., 2019; Marin-Sanz et al., 2023).
4 Modern Genetic Approaches
4.1 RNA interference (RNAi)
RNAi technology can silence some gluten-related genes, thereby significantly reducing the expression of α-, γ- and ω -alcohol-soluble proteins. Studies have found that after RNAi treatment, the gluten content in wheat grains can decrease to 97%, and the stimulating effect of this flour on T cells in patients with celiac disease is significantly weakened, with little impact on dough quality (Altenbach et al., 2019; Garcia-Molina et al., 2019; Jouanin et al., 2019; Sharma et al., 2020). However, because the builders of RNAi remain in the genome, this type of wheat is often identified as genetically modified crops and is subject to regulatory restrictions (Jouanin et al., 2019; Sharma et al., 2020).
4.2 CRISPR/Cas genome editing
CRISPR/Cas9 technology can precisely knock out or modify multiple gluten genes, such as α- and γ -glycolin. Many studies have obtained wheat mutants of low trough protein, whose immune reactivity has decreased by approximately 85%, and some strains have no transgenic residue (Sanchet-Leon et al., 2017; Jouanin, 2019; Jouanin et al., 2019; 2020; Liu et al., 2023; Pourmohammadi et al., 2023; Bennur et al., 2024) (Figure 1). CRISPR/Cas9 can also replace some immunogenic epitopes with "safe" epitopes, which can not only improve the quality of bread but also reduce the risk of celiac disease (Jouanin et al., 2020; Liu et al., 2023). However, if gluten is completely knocked out, it may affect the processing performance of the dough. Therefore, a balance needs to be struck between safety and quality (Jouanin et al., 2019; 2020; Liu et al., 2023).
|
Figure 1 Breeding of a green super wheat variety through CRISPR/Cas9 (Adopted from Bennur et al., 2024) |
4.3 TILLING (targeting induced local lesions in genomes)
TILLING is a non-transgenic mutagenesis method that uses mutagenesis and then screens to identify mutants of the target gene. TILLING obtained some wheat materials with lower gluten content and weakened immunogenicity on genes such as DEMETER and DRE2 that regulate gluten. These materials can also retain high-molecular-weight gluten subunits, so the processing performance of the bread is basically maintained (Moehs et al., 2019; Wen et al., 2022). However, some mutants may present problems such as decreased pollen viability, which still require further improvement (Wen et al., 2022).
4.4 Transgenic approaches
Transgenic methods involve adjusting the composition of gluten by introducing or silencing specific genes. For instance, introducing wild-type genes into mutants can restore the original phenotype. Alternatively, silencing certain protein subunits with RNAi can also reduce immunogenicity (Vasil and Anderson, 1997; Altenbach et al., 2019; Moehs et al., 2019). Although this method works well in the laboratory, it is limited by public acceptance and policy regulations in practical promotion (Vasil and Anderson, 1997; Altenbach et al., 2019).
5 Case Study: CRISPR/Cas9 Editing of Gliadin Genes in Bread Wheat
5.1 Research background: α-gliadins as key immunogenic proteins
The α-gliadins in wheat gluten contain many immune epitopes related to Celiac disease (CD) and are the main proteins that cause immune responses in patients. Because of the large number and complex distribution of α-, γ- and ω -olysis protein genes, it is difficult for traditional breeding to remove all immune epitopes (Jouanin et al., 2019; Jouanin et al., 2020; Guzmán-López et al., 2021) (Figure 2).
|
Figure 2 MUSCLE alignment of Amps clusters from the neighbor-joining dendrogram. (A) Cluster 1 of Amps present in lines with DP genotype. (B) Cluster 1 of Amps present in lines with BW208 genotype. (C) Cluster 22 of Amps present in lines with BW208 genotype. DP: Don Pedro. Amps: unique denoised amplicons (Adopted from Guzmán-López et al., 2021) |
5.2 Experimental strategy: multiplex CRISPR editing of gliadin gene families
Researchers employed multiple Sgrnas to target the conserved regions of the α-, γ-, and ω -olysin gene families. Through multiple CRISPR/Cas9 editing, they can simultaneously knock out or modify multiple gene copies, thereby significantly reducing the expression of immunogenic epitopes (Jouanin et al., 2019; Guzman Lopez et al., 2021; Yu et al., 2023; Sanchez-Leon et al., 2024).
5.3 Key outcomes: reduction in immunogenic epitopes, retention of acceptable dough properties
The contents of α-, γ- and ω -gliolysis proteins in these CRISPR mutants decreased significantly. In some materials, the total amount of gluten decreased by up to 97%, and the immune epitopes also decreased significantly (Guzmán-López et al., 2021; Yu et al., 2023; Sanchez-Leon et al., 2024). Meanwhile, the edited flour performed normally in terms of dough performance and baking quality, with no obvious problems (Yu et al., 2023).
5.4 Clinical/functional assessment: immunoreactivity tests with celiac patient sera
Serum tests using patients with celiac disease revealed that the immune reactivity of edited wheat was significantly reduced, with some materials showing a decrease of up to 47 times (Yu et al., 2023). In addition, its safety was verified by studies using animal models and T-cell activation experiments (Jouanin et al., 2020; Yu et al., 2023).
5.5 Broader implications: toward gluten-safe wheat lines for commercial production
The multiple editing of CRISPR/Cas9 provides a way to cultivate wheat with low immunogenicity or even "gluten-free". Some editing strains have achieved no transgenic residue and are commercially viable (Liang et al., 2017; Jouanin et al., 2020; Sanchez-Leon et al., 2024). In the future, if high-throughput screening and precise epitope editing are combined, it is expected to obtain "celiac disease-safe" wheat that is both safe and has good processing performance (Jouanin et al., 2019; 2020; Guzmán-López et al., 2021; Yu et al., 2023).
6 Challenges and Trade-Offs
6.1 Maintaining dough quality and baking performance with reduced gluten
Gluten is very important for wheat dough and baking quality. Reducing gluten, especially glycolin, often leads to a decrease in dough elasticity and poor extensibility, affecting the structure and taste of foods such as bread (Gil-Humanes et al., 2014; Sharma et al., 2020). Some studies have obtained low-alcohol-soluble protein wheat using RNAi and found that its dough stability and taste are close to those of common wheat, but it still needs to be optimized to meet industrial demands (Gil-Humanes et al., 2014; Wang et al., 2020). In addition, adding excipients such as low-ester pectin, dietary fiber or polyphenols can partially make up for the deficiency of dough network and improve rheology and texture (Girard and Awika, 2020; Cui et al., 2022; Li et al., 2023).
6.2 Balancing nutritional value (protein composition changes)
Low-gluten protein may alter protein composition, influencing the proportion of amino acids and nutritional value. Some low-alcohol-soluble protein wheat strains have increased contents of essential amino acids such as lysine and higher nutritional value (Gil-Humanes et al., 2014). However, some studies have found that when gluten decreases, the expression of other storage proteins (such as high-molecular-weight gluten subunits) may increase. Therefore, attention should be paid to overall protein quality and digestibility (Gil-Humanes et al., 2014; Nye-Wood et al., 2021).
6.3 Agronomic performance and yield stability
Gluten genes are closely related to agronomic traits such as wheat grain development and yield. Some improved strains showed no significant changes in yield and grain quality after reducing gluten (Landolfi et al., 2021; Buczek, 2024). However, some studies have pointed out that if the gluten level drops too much, it may affect indicators such as grain filling and 1000-grain weight. Therefore, a balance needs to be struck between reducing immunogenicity and maintaining high and stable yields (Wang et al., 2020; Buczek, 2024).
6.4 Regulatory and biosafety issues for gene-edited crops
Gene editing technologies such as CRISPR/Cas are not considered genetically modified in some countries, but policies are not consistent worldwide. Some countries require strict safety assessment and label management, which may affect the promotion of new varieties (Wang et al., 2020; Nye-Wood et al., 2021). At the same time, attention should also be paid to the off-target effects and ecological risks that may be brought about by gene editing.
6.5 Public perception and acceptance
Low-gluten wheat can help patients with celiac disease, but most people do not need a gluten-free diet. The limited acceptance of gene-edited and genetically modified crops by the public, coupled with the sometimes misleading media, may lead some healthy people to blindly choose gluten-free foods, which instead affects nutritional balance (Gil-Humanes et al., 2014; Sharma et al., 2020). Therefore, it is of great significance to enhance popular science publicity and risk communication.
7 Future Perspectives
7.1 Combining genetic editing with breeding strategies
To reduce gluten in wheat in the future, gene editing (such as CRISPR/Cas9) and molecular marker-assisted breeding (MAS) can be combined. First, use CRISPR/Cas9 to knock out or modify the immune epitopes in α-, γ-, and ω -alcohol-soluble proteins. Then, through molecular marker screening and backcrossing, introduce the low trough protein traits into the main cultivated varieties (Jouanin et al., 2019; 2020; Sharma et al., 2020; Wang et al., 2020; Bennur et al., 2024). This combination of multiple methods can maintain both yield and quality simultaneously, and also make up for the deficiencies of a single method, improving the safety and practicability of new varieties (Jouanin et al., 2017; 2019; 2020).
7.2 Toward personalized wheat varieties for different dietary needs
As research on celiac disease and non-celiac gluten sensitivity deepens, in the future, different types of wheat can be developed according to the needs of different groups of people. For instance, wheat without immune epitopes was designed for patients with celiac disease, while some gluten was retained for healthy people to ensure dough quality (Wang et al., 2020; Pourmohammadi et al., 2023). This can make wheat varieties more diverse, meeting both health needs and preserving the taste of food (Jouanin et al., 2017; Wang et al., 2020; Pourmohammadi et al., 2023).
7.3 Advances in multi-omics approaches (genomics, proteomics, immunopeptidomics)
The development of multi-omics technology has greatly accelerated the analysis and functional research of gluten genes. High-throughput sequencing can quickly identify target genes. Proteomic and immune peptide profiling analysis can locate immune epitopes, monitor the effect of gene editing, and also evaluate overall protein changes (Jouanin et al., 2019; Sharma et al., 2020; Wang et al., 2020). These methods provide strong support for screening safe materials and optimizing protein composition (Jouanin et al., 2019; Wang et al., 2020).
7.4 Potential of synthetic biology for novel low-gluten grains
Synthetic biology offers people the opportunity to redesign protein structures and even create brand-new grains. Low protein grains without immunogenicity but maintaining ideal dough performance can be obtained through artificial synthesis or gene reconstruction (Wang et al., 2020; Li et al., 2021). Meanwhile, synthetic biology can also be used to cultivate alternative low protein crops, providing more raw material sources for healthy foods (Li et al., 2021).
8 Conclusion
In recent years, researchers have employed a variety of genetic methods to reduce the gluten content in wheat and lower the risk of diseases such as celiac disease. Common methods include RNA interference (RNAi), CRISPR/Cas9 gene editing, TILLING (targeted mutagenesis), and molecular marker-assisted breeding. RNAi and CRISPR/Cas9 can efficiently silence or knock out α-, γ-, and ω -alcohol-soluble protein genes, significantly reducing gluten content and immune reactivity. TILLING, on the other hand, screens mutants through mutagenesis to achieve non-transgenic trough protein breeding. The progress of molecular markers and genomics has also accelerated the breeding of superior low-gluten wheat strains.
These methods can not only provide safer staple foods for people with celiac disease and gluten sensitivity, but also meet the global demand for healthy food. Low immunogenicity wheat is expected to reduce people's reliance on a strict gluten-free diet and improve the quality of life of patients. At the same time, it can also maintain the processing performance of the dough, facilitating the production of foods such as bread. The promotion of low-gluten wheat will also drive the diversification and innovation of the health food market.
The future improvement direction may integrate multiple technologies, such as multi-genome editing, molecular breeding and multi-omics screening. New tools such as CRISPR/Cas9 are expected to precisely replace or eliminate immune epitopes, maintaining food quality while ensuring safety. Multi-omics technologies (genomics, proteomics, and immunopeptidomics) will help identify safer wheat materials and promote the development of personalized and customized staple foods. Emerging methods such as synthetic biology may also create brand-new low-gluten grains, expanding the sources of healthy food.
Acknowledgments
We are grateful to Ms. Yan for her critically reading the manuscript and providing valuable feedback.
Conflict of Interest Disclosure
The authors affirm that this research was conducted without any commercial or financial relationships that could be construed as a potential conflict of interest.
Altenbach S., Chang H., Yu X., Seabourn B., Green P., and Alaedini A., 2019, Elimination of Omega-1,2 Gliadins from bread wheat (Triticum aestivum) flour: effects on immunogenic potential and end-use quality, Frontiers in Plant Science, 10: 580.
https://doi.org/10.3389/fpls.2019.00580
Asri N., Rostami-Nejad M., Anderson R., and Rostami K., 2021, The gluten gene: unlocking the understanding of gluten sensitivity and intolerance, The Application of Clinical Genetics, 14: 37-50.
https://doi.org/10.2147/TACG.S276596
Bennur S., Ram M., and Shalini, 2024, Marker-assisted breeding techniques for the development of gluten-free wheat varieties: a comprehensive review, Journal of Advances in Biology & Biotechnology, 27(5): 256-267.
https://doi.org/10.9734/jabb/2024/v27i5785
Biesiekierski J., 2017, What is gluten? Journal of Gastroenterology and Hepatology, 32: 78-81.
https://doi.org/10.1111/jgh.13703
Buczek J., 2024, The effect of tillage systems and weed control methods on grain yield and gluten protein compositional and content-related changes in hybrid bread wheat, Agriculture, 14(9): 1558.
https://doi.org/10.3390/agriculture14091558
Call L., Kapeller M., Grausgruber H., Reiter E., Schoenlechner R., and D’amico S., 2020, Effects of species and breeding on wheat protein composition, Journal of Cereal Science, 93: 102974.
https://doi.org/10.1016/j.jcs.2020.102974
Cui Y., Chen J., and Zhang S., 2022, The effect of degree of esterification of pectin on the interaction between pectin and wheat gluten protein, Food Hydrocolloids, 136(Pt A): 108272.
https://doi.org/10.1016/j.foodhyd.2022.108272
García-Molina M., Giménez M., Sánchez-León S., and Barro F., 2019, Gluten free wheat: are we there? Nutrients, 11(3): 487.
https://doi.org/10.3390/nu11030487
Gil‐Humanes J., Pistón F., Altamirano-Fortoul R., Real A., Comino I., Sousa C., Rosell C., and Barro F., 2014, Reduced-gliadin wheat bread: an alternative to the gluten-free diet for consumers suffering gluten-related pathologies, PLoS ONE, 9(3): e90898.
https://doi.org/10.1371/journal.pone.0090898
Girard A., and Awika J., 2020, Effects of edible plant polyphenols on gluten protein functionality and potential applications of polyphenol-gluten interactions, Comprehensive reviews in food science and food safety, 19(4): 2164-2199.
https://doi.org/10.1111/1541-4337.12572
Guzmán-López M., Marín-Sanz M., Sánchez-León S., and Barro F., 2021, A bioinformatic workflow for InDel analysis in the wheat multi-copy α-gliadin gene family engineered with CRISPR/Cas9, International Journal of Molecular Sciences, 22(23): 13076.
https://doi.org/10.3390/ijms222313076
Jouanin A., Gilissen L., Boyd L., Cockram J., Leigh F., Wallington E., Van Den Broeck H., Van Der Meer I., Schaart J., Visser R., and Smulders M., 2017, Food processing and breeding strategies for coeliac-safe and healthy wheat products, Food Research International, 110: 11-21.
https://doi.org/10.1016/j.foodres.2017.04.025
Jouanin A., Gilissen L., Schaart J., Leigh F., Cockram J., Wallington E., Boyd L., Van Den Broeck H., Van Der Meer I., America A., Visser R., and Smulders M., 2020, CRISPR/Cas9 gene editing of gluten in wheat to reduce gluten content and exposure—reviewing methods to screen for coeliac safety, Frontiers in Nutrition, 7: 51.
https://doi.org/10.3389/fnut.2020.00051
Jouanin A., Schaart J., Boyd L., Cockram J., Leigh F., Bates R., Wallington E., Visser R., and Smulders M., 2019, Outlook for coeliac disease patients: towards bread wheat with hypoimmunogenic gluten by gene editing of α- and γ-gliadin gene families, BMC Plant Biology, 19: 333.
https://doi.org/10.1186/s12870-019-1889-5
Landolfi V., Visioli G., and Blandino M., 2021, Effect of nitrogen fertilization and fungicide application at heading on the gluten protein composition and rheological quality of wheat, Agronomy, 11(9): 1687.
https://doi.org/10.3390/agronomy11091687
Li M., Li L., Sun B., and Ma S., 2023, Interaction of wheat bran dietary fiber-gluten protein affects dough product: A critical review, International Journal of Biological Macromolecules, 255: 128199.
https://doi.org/10.1016/j.ijbiomac.2023.128199
Li S., Zhang C., Li J., Yan L., Wang N., and Xia L., 2021, Present and future prospects for wheat improvement through genome editing and advanced technologies, Plant Communications, 2(4): 100211.
https://doi.org/10.1016/j.xplc.2021.100211
Liang Z., Chen K., Li T., Zhang Y., Wang Y., Zhao Q., Liu J., Zhang H., Liu C., Ran Y., and Gao C., 2017, Efficient DNA-free genome editing of bread wheat using CRISPR/Cas9 ribonucleoprotein complexes, Nature Communications, 8: 14261.
https://doi.org/10.1038/ncomms14261
Liu D., Yang H., Zhang Z., Chen Q., Guo W., Rossi V., Xin M., Du J., Hu Z., Liu J., Peng H., Ni Z., Su Q., and Yao Y., 2023, An elite γ-gliadin allele improves end-use quality in wheat, The New Phytologist, 239(1): 87-101.
https://doi.org/10.1111/nph.18722
Marín-Sanz M., Barro F., and Sánchez-León S., 2023, Unraveling the celiac disease-related immunogenic complexes in a set of wheat and tritordeum genotypes: implications for low-gluten precision breeding in cereal crops, Frontiers in Plant Science, 14: 1171882.
https://doi.org/10.3389/fpls.2023.1171882
Moehs C., Austill W., Holm A., Large T., Loeffler D., Mullenberg J., Schnable P., Skinner W., Van Boxtel J., Wu L., and McGuire C., 2019, Development of decreased-gluten wheat enabled by determination of the genetic basis of lys3a Barley1, Plant Physiology, 179: 1692-1703.
https://doi.org/10.1104/pp.18.00771
Nye-Wood M., Juhász A., Bose U., and Colgrave M., 2021, Proteome analysis and epitope mapping in a commercial reduced-gluten wheat product, Frontiers in Nutrition, 8: 705822.
https://doi.org/10.3389/fnut.2021.705822
Ozuna C., and Barro F., 2018, Characterization of gluten proteins and celiac disease-related immunogenic epitopes in the Triticeae: cereal domestication and breeding contributed to decrease the content of gliadins and gluten, Molecular Breeding, 38: 1-16.
https://doi.org/10.1007/s11032-018-0779-0
Pilolli R., Gadaleta A., Di Stasio L., Lamonaca A., De Angelis E., Nigro D., De Angelis M., Mamone G., and Monaci L., 2019, A comprehensive peptidomic approach to characterize the protein profile of selected durum wheat genotypes: implication for coeliac disease and wheat allergy, Nutrients, 11(10): 2321.
https://doi.org/10.3390/nu11102321
Pilolli R., Gadaleta A., Mamone G., Nigro D., De Angelis E., Montemurro N., and Monaci L., 2019, Scouting for naturally low-toxicity wheat genotypes by a multidisciplinary approach, Scientific Reports, 9: 1646.
https://doi.org/10.1038/s41598-018-36845-8
Pourmohammadi K., Abedi E., and Hashemi S., 2023, Gliadin and glutenin genomes and their effects on the technological aspect of wheat-based products, Current Research in Food Science, 7: 100622.
https://doi.org/10.1016/j.crfs.2023.100622
Sánchez-León S., Gil‐Humanes J., Ozuna C., Giménez M., Sousa C., Voytas D., and Barro F., 2017, Low‐gluten, nontransgenic wheat engineered with CRISPR/Cas9, Plant Biotechnology Journal, 16: 902-910.
https://doi.org/10.1111/pbi.12837
Sánchez-León S., Marín-Sanz M., Guzmán-López M., Gavilán-Camacho M., Simón E., and Barro F., 2024, CRISPR/Cas9-mediated multiplex gene editing of gamma and omega gliadins: paving the way for gliadin-free wheat, Journal of Experimental Botany, 75: 7079-7095.
https://doi.org/10.1093/jxb/erae376
Schalk K., Lexhaller B., Koehler P., and Scherf K., 2017, Isolation and characterization of gluten protein types from wheat, rye, barley and oats for use as reference materials, PLoS ONE, 12(2): e0172819.
https://doi.org/10.1371/journal.pone.0172819
Sharma N., Bhatia S., Chunduri V., Kaur S., Sharma S., Kapoor P., Kumari A., and Garg M., 2020, Pathogenesis of celiac disease and other gluten related disorders in wheat and strategies for mitigating them, Frontiers in Nutrition, 7: 6.
https://doi.org/10.3389/fnut.2020.00006
Shewry P., 2019, What is gluten—why is it special? Frontiers in Nutrition, 6: 101.
https://doi.org/10.3389/fnut.2019.00101
Shewry P., and Belton P., 2024, What do we really understand about wheat gluten structure and functionality? Journal of Cereal Science, 117: 103895.
https://doi.org/10.1016/j.jcs.2024.103895
Shewry P., Halford N., Belton P., and Tatham A., 2002, The structure and properties of gluten: an elastic protein from wheat grain, Philosophical transactions of the Royal Society of London. Series B, Biological Sciences, 357(1418): 133-142.
https://doi.org/10.1098/RSTB.2001.1024
Vasil I., and Anderson O., 1997, Genetic engineering of wheat gluten, Trends in Plant Science, 2: 292-297.
https://doi.org/10.1016/S1360-1385(97)89950-5
Wang D., Li F., Cao S., and Zhang K., 2020, Genomic and functional genomics analyses of gluten proteins and prospect for simultaneous improvement of end-use and health-related traits in wheat, TAG. Theoretical and Applied Genetics. Theoretische Und Angewandte Genetik, 133: 1521-1539.
https://doi.org/10.1007/s00122-020-03557-5
Wen N., Osorio C., Brew-Appiah R., Mejías J., Alam T., Kashyap S., Reinbothe S., Reinbothe C., Moehs C., Von Wettstein D., and Rustgi S., 2022, Targeting induced local lesions in the wheat DEMETER and DRE2 genes, responsible for transcriptional derepression of wheat gluten proteins in the developing endosperm, Frontiers in Nutrition, 9: 847635.
https://doi.org/10.3389/fnut.2022.847635
Wieser H., Koehler P., and Scherf K., 2022, Chemistry of wheat gluten proteins: Qualitative composition, Cereal Chemistry, 100(1): 23-35.
https://doi.org/10.1002/cche.10572
Yu Z., Yunusbaev U., Fritz A., Tilley M., Akhunova A., Trick H., and Akhunov E., 2023, CRISPR‐based editing of the ω‐ and γ‐gliadin gene clusters reduces wheat immunoreactivity without affecting grain protein quality, Plant Biotechnology Journal, 22: 892-903.
https://doi.org/10.1111/pbi.14231
Yu Z., Yunusbaev U., Fritz A., Tilley M., Akhunova A., Trick H., and Akhunov E., 2023, CRISPR-based editing of the ω- and γ-gliadin gene clusters reduces wheat immunoreactivity without affecting grain protein quality, bioRxiv.
https://doi.org/10.1101/2023.01.30.526376

. FPDF(win)
. FPDF(mac)
. HTML
. Online fPDF
Associated material
. Readers' comments
Other articles by authors
. Guiping Zhang
. Wei Wang
Related articles
. Wheat
. Gluten
. Gene editing
. CRISPR/Cas9
. RNA interference
Tools
. Post a comment
.png)
.png)